Related Experiment Video
Updated: Mar 29, 2026
07:59
A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes
Published on: March 25, 2014
15.7K
Multi-Epitope DNA-Based Feline Immunodeficiency Virus Vaccine Construct Designed by Immunoinformatic and Machine
Tyler Michalka1, Abid Ullah Shah1, Tiffany Liang1
1Department of Veterinary Biomedical Sciences, Lewyt College of Veterinary Medicine, Long Island University, Brookville, NY 11548, USA.
Pathogens (Basel, Switzerland)
|March 28, 2026
Summary
Artificial intelligence and immunoinformatics designed a novel DNA vaccine for Feline Immunodeficiency Virus (FIV). This FIV vaccine candidate shows promise for both feline health and advancing Human Immunodeficiency Virus (HIV) vaccine development.
Area of Science:
- Veterinary Medicine
- Immunology
- Bioinformatics
Background:
- Feline immunodeficiency virus (FIV) shares similarities with human immunodeficiency virus (HIV), making it a relevant model for HIV vaccine research.
- Developing effective vaccines against lentiviruses like FIV and HIV remains a critical challenge.
Purpose of the Study:
- To design a novel multi-epitope DNA vaccine for FIV using artificial intelligence (AI) and immunoinformatics.
- To evaluate the immunogenic potential and safety of the designed FIV vaccine candidate.
Main Methods:
- AI and immunoinformatics were used to identify conserved FIV epitopes from gag, pol, and env genes.
- Predicted B-cell and T-cell epitopes were assessed for immunogenicity, allergenicity, and toxicity.
- Epitopes were linked to the immune adjuvant PADRE, and structural analyses were performed.
Main Results:
- The designed FIV vaccine construct demonstrated stability, solubility, and biocompatibility.
- The vaccine structure was well-folded and predicted to bind Toll-like receptor 9 (TLR9).
- The construct is expected to elicit robust humoral and cellular immune responses.
Conclusions:
- A promising FIV DNA vaccine candidate has been identified through AI-driven design.
- The study provides valuable insights for the development of next-generation HIV vaccines.
- This approach highlights the potential of AI and immunoinformatics in vaccine design for lentiviral infections.
